Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:6/13/2019)... ... ... In Partnership with the Smiles for Everyone Foundation , Monarch ... TX office on July 13th. , Dental services provided include same-day procedures such as ... more information, please visit the Monarch Dental website . , About Monarch Dental® ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... in healthcare, today announced that Jon Elwell, the company’s CEO, has been confirmed ... DirectTrust is a non-profit health care industry alliance created to support secure, ...
(Date:6/13/2019)... ... June 13, 2019 , ... This ... and Charles “Charlie” Schadewald as the newest members of its board. Prior to ... NICA’s Advisory Committee. The NICA Advisory Committee is comprised of senior leadership members ...
(Date:6/12/2019)... , ... June 12, 2019 , ... ... a quality assurance expert with more than 25 years of experience in quality ... for all classes of medical devices, has joined NDA Partners as an Expert ...
(Date:6/12/2019)... ... June 12, 2019 , ... The HACCP SmartStep2 ... of Best Sanitizers’ HACCP Footwear Sanitizing Unit equipment. The HACCP SmartStep2 adds an ... clinical research labs, and clean rooms by reducing cross-contamination from footwear before employees ...
Breaking Medicine News(10 mins):
... S.C., Dec. 13 Robert Rhodes has been,appointed ... TCC of,South Carolina, a third-party administrator of health ... counsel and assistant vice,president of BlueCross BlueShield of ... the Blue Cross and Blue Shield Association. He,brings ...
... wouldn,t use the cholesterol-lowering drug safely , , THURSDAY, Dec. 13 ... U.S. Food and Drug Administration advisers have voted to deny ... available over the counter. , In a 10 to 2 ... it would be too complicated for consumers to determine on ...
... that may encourage the addiction , THURSDAY, Dec. 13 ... haplotype of a particular gene may be at increased ... are clusters of genetic polymorphisms or variations. , In ... (UKMC)collected blood samples and clinical data from almost 700 ...
... President and CEO of,Chicago-based Oral Health America, is ... the Friends of the National Institute of Dental,and ... behalf of oral health have made a,difference for ... NIDCR. "He has approached oral health from multiple,angles, ...
... Infrastructure Serves as Network Foundation for the Hospital,s ... State-of-the-Art Cardiothoracic Center, ... today announced the completion of a new network,infrastructure to ... at Basildon and Thurrock University Hospitals, part,of the NHS ...
... Dec. 13 The American Stock Exchange(R),(Amex(R)) today lists ... Inc.,under the ticker symbol QGP and QGP.U. One unit ... Warrants (QGP.WS.A), and two Class "B" Warrants,(QGP.WS.B). The common ... the,offering, with the warrants listed at a later date ...
Cached Medicine News:
... intravascular catheters provide a simple, efficient ... pressures in the heart or cardiovascular ... are ideal for high fidelity pressure ... from 2 to 7 French and ...
... Mikro-Tip pressure intravascular catheters provide a ... of measuring pressures in the heart ... Mikro-Tip catheters are ideal for high ... in size from 2 to 7 ...
... intravascular catheters provide a simple, efficient ... pressures in the heart or cardiovascular ... are ideal for high fidelity pressure ... from 2 to 7 French and ...
... sensor catheters incorporate a lumen ... wire, or high-speed injection/guide wire. ... injection has two laterally opposed ... open-end pigtail extension for use ...
Medicine Products:
(Date:6/13/2019)... ... , ... Homecare Homebase (HCHB) the nation’s leader in mobile ... of the HCHB Intelligence Suite, at the company’s annual Users Conference this week ... efficient routing, mapping and scheduling for home health agencies to automate the scheduling ...
(Date:6/13/2019)... ... June 13, 2019 , ... Port-A-Wall, an expanding innovator ... year anniversary. Offering a simple but effective solution to space optimization and ... categories—from home and travel use to large-scale emergency response to healthcare screening. ...
(Date:6/12/2019)... ... June 12, 2019 , ... Through their Sidewalk Angels Foundation ... share the importance of protecting your entire family from Lyme and other tick-borne diseases. ... how much fur we have. , Through this partnership SWA and GLA look ...
Breaking Medicine Technology:
... Warner Chilcott plc (Nasdaq: WCRX) today announced that it will issue its ... 6, 2010 . , , , ... press release, the Company will host a conference call for all interested parties on ... review the results. To participate in the call, please dial (877) 354-4056 in ...
... HORSHAM, Pa. , July 28 Topaz Pharmaceuticals Inc., a ... cream, which it is developing as a potential  treatment of Pediculus ... , , ... meeting of the Society for Pediatric Dermatology in Portland, ...
Cached Medicine Technology: